These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 11886436)

  • 1. Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b.
    Stam TC; Swaak AJ; Kruit WH; Eggermont AM
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():79-83. PubMed ID: 11886436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcome.
    Bouwhuis MG; Collette S; Suciu S; de Groot ER; Kruit WH; Ten Hagen TL; Aarden LA; Eggermont AM; Swaak AJ;
    Melanoma Res; 2011 Aug; 21(4):344-51. PubMed ID: 21546857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ferritin response in adult Still's disease: specificity and relationship to outcome.
    Evensen KJ; Swaak TJ; Nossent JC
    Scand J Rheumatol; 2007; 36(2):107-10. PubMed ID: 17476616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron saturation of serum ferritin in patients with adult onset Still's disease.
    ten Kate J; Drenth JP; Kahn MF; van Deursen C
    J Rheumatol; 2001 Oct; 28(10):2213-5. PubMed ID: 11669158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease.
    Van Reeth C; Le Moel G; Lasne Y; Revenant MC; Agneray J; Kahn MF; Bourgeois P
    J Rheumatol; 1994 May; 21(5):890-5. PubMed ID: 8064731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
    Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
    J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
    PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.
    Shimojima Y; Kishida D; Ueno KI; Ushiyama S; Ichikawa T; Sekijima Y
    J Rheumatol; 2019 Oct; 46(10):1268-1276. PubMed ID: 30770498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment.
    Ascierto PA; Napolitano M; Celentano E; Simeone E; Gentilcore G; Daponte A; Capone M; Caracò C; Calemma R; Beneduce G; Cerrone M; De Rosa V; Palmieri G; Castello G; Kirkwood JM; Marincola FM; Mozzillo N
    J Transl Med; 2010 Aug; 8():76. PubMed ID: 20712892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum ferritin as a marker for adult Still's disease activity.
    Schwarz-Eywill M; Heilig B; Bauer H; Breitbart A; Pezzutto A
    Ann Rheum Dis; 1992 May; 51(5):683-5. PubMed ID: 1616341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
    Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
    Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum caeruloplasmin level in a patient with adult Still's disease.
    Kemény L; Mehravaran M; Dobozy A
    Br J Dermatol; 2002 Mar; 146(3):508-10. PubMed ID: 11952555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.
    Feelders RA; Vreugdenhil G; Eggermont AM; Kuiper-Kramer PA; van Eijk HG; Swaak AJ
    Eur J Clin Invest; 1998 Jul; 28(7):520-7. PubMed ID: 9726030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-onset Still's disease: clinical, serological and therapeutic considerations.
    Iliou C; Papagoras C; Tsifetaki N; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2013; 31(1):47-52. PubMed ID: 23010097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 72-year-old female with adult Still's disease.
    Koga T; Tokunaga N; Ichikawa Y; Oizumi K
    Intern Med; 1992 Dec; 31(12):1356-8. PubMed ID: 1300170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
    Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
    J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.